DK2467136T3 - 4-methylpyrazolformuleringer - Google Patents

4-methylpyrazolformuleringer

Info

Publication number
DK2467136T3
DK2467136T3 DK10836472.0T DK10836472T DK2467136T3 DK 2467136 T3 DK2467136 T3 DK 2467136T3 DK 10836472 T DK10836472 T DK 10836472T DK 2467136 T3 DK2467136 T3 DK 2467136T3
Authority
DK
Denmark
Prior art keywords
methylpyrazole
formulations
methylpyrazole formulations
Prior art date
Application number
DK10836472.0T
Other languages
English (en)
Inventor
Thomas E Daley
Kathy Powell
Olga Jarzebinski
Original Assignee
Raptor Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raptor Therapeutics Inc filed Critical Raptor Therapeutics Inc
Application granted granted Critical
Publication of DK2467136T3 publication Critical patent/DK2467136T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK10836472.0T 2009-12-07 2010-12-06 4-methylpyrazolformuleringer DK2467136T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26738909P 2009-12-07 2009-12-07
PCT/US2010/059065 WO2011071805A1 (en) 2009-12-07 2010-12-06 4-methylpyrazole formulations

Publications (1)

Publication Number Publication Date
DK2467136T3 true DK2467136T3 (da) 2014-08-11

Family

ID=44145870

Family Applications (2)

Application Number Title Priority Date Filing Date
DK14150138.7T DK2774612T3 (da) 2009-12-07 2010-12-06 4-Methylpyrazolformuleringer
DK10836472.0T DK2467136T3 (da) 2009-12-07 2010-12-06 4-methylpyrazolformuleringer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK14150138.7T DK2774612T3 (da) 2009-12-07 2010-12-06 4-Methylpyrazolformuleringer

Country Status (13)

Country Link
US (2) US9173850B2 (da)
EP (3) EP3300732A1 (da)
JP (1) JP5678088B2 (da)
KR (1) KR101464053B1 (da)
CN (1) CN102630162B (da)
AU (1) AU2010328375B2 (da)
DK (2) DK2774612T3 (da)
ES (2) ES2646201T3 (da)
HK (1) HK1201759A1 (da)
PT (2) PT2467136E (da)
SG (2) SG10201710156RA (da)
TW (1) TWI490209B (da)
WO (1) WO2011071805A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5800669B2 (ja) 2011-10-18 2015-10-28 大阪化成株式会社 抗菌・抗カビ性付与剤、繊維類加工剤及び抗菌・抗カビ性繊維類の製造方法
EP3323412A1 (en) * 2016-11-17 2018-05-23 Amalicon Holding AG Formulation comprising 4-methylpyrazole
KR102150040B1 (ko) * 2018-10-16 2020-08-31 한국과학기술원 4-메틸피라졸을 포함하는 간암 예방 또는 치료용 조성물
CN109452286B (zh) * 2018-11-12 2020-11-06 青岛大学 甲吡唑在杀灭松材线虫中的应用
CN109381458B (zh) * 2018-12-16 2020-09-01 李志武 甲吡唑及其盐在制备抗癫痫药物中的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197787B1 (en) * 1997-03-03 2001-03-06 Sanofi-Synthelabo Pharmaceutical formulations containing poorly soluble drug substances
US6120806A (en) 1997-06-25 2000-09-19 Whitmire; David R. Oral formulations for controlled release of alcohol deterrents
FR2807645B1 (fr) * 2000-04-12 2005-06-03 Oreal Utilisation d'inhibiteurs de l'alcool deshydrogenase dans le traitement cosmetique des matieres keratiniques
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
ITBO20020284A1 (it) 2002-05-14 2003-11-14 Ima Spa Macchina opercolatrice
WO2004004628A1 (ja) 2002-07-05 2004-01-15 Shionogi Qualicaps Co., Ltd. カプセル充填封緘装置
ATE531368T1 (de) * 2003-08-29 2011-11-15 Veloxis Pharmaceuticals As Tacrolimus enthaltende zusammensetzungen mit modifizierter freisetzung
AU2004268661A1 (en) * 2003-09-02 2005-03-10 Alza Corporation Novel drug compositions and dosage forms of topiramate
WO2005084392A2 (en) * 2004-03-03 2005-09-15 Convivia 4-methylpyrazole formulations for inhibiting ethanol intolerance

Also Published As

Publication number Publication date
KR20120115483A (ko) 2012-10-18
EP2774612A1 (en) 2014-09-10
TW201127816A (en) 2011-08-16
ES2646201T3 (es) 2017-12-12
SG10201710156RA (en) 2018-01-30
DK2774612T3 (da) 2017-11-20
US20160151332A1 (en) 2016-06-02
SG181566A1 (en) 2012-07-30
US9173850B2 (en) 2015-11-03
EP2774612B1 (en) 2017-08-30
KR101464053B1 (ko) 2014-11-20
JP2013512930A (ja) 2013-04-18
PT2774612T (pt) 2017-11-17
ES2487634T3 (es) 2014-08-22
PT2467136E (pt) 2014-08-26
CN102630162B (zh) 2014-07-09
WO2011071805A1 (en) 2011-06-16
AU2010328375A1 (en) 2012-04-05
HK1201759A1 (en) 2015-09-11
JP5678088B2 (ja) 2015-02-25
EP2467136A1 (en) 2012-06-27
US20120244217A1 (en) 2012-09-27
TWI490209B (zh) 2015-07-01
CN102630162A (zh) 2012-08-08
EP2467136B1 (en) 2014-05-07
EP2467136A4 (en) 2013-01-16
EP3300732A1 (en) 2018-04-04
AU2010328375B2 (en) 2015-08-27

Similar Documents

Publication Publication Date Title
DK2414015T3 (da) Laryngoskopsystem
DE112010004215A5 (de) Hydrostataktor
DE112010002949A5 (de) Kupplungstastpunkte
DK2411442T4 (da) Umættet polyesterresin
BRPI1008827A2 (pt) deisobutenizador
DK2430035T3 (da) Uracylspipooxetannukleosider
BRPI1014968A2 (pt) subalargador
BR112013013695A2 (pt) derivado de pirazol
DE112010002728A5 (de) Turboinhalator
BRPI1009465A2 (pt) Formulação
DE112009005323A5 (de) Hebelarmprüfmaschine
DE112010004249A5 (de) Spindelaktor
DE112009005462T8 (de) Lenkungsssteuervorrichtung
BR112012004964A2 (pt) girocóptero
BRPI1008070A2 (pt) tricianoboratos
BR112012016923A2 (pt) Derivados de pirazol
DK2483126T3 (da) Skinnekøretøj
DE112010004865T8 (de) Lamellennassreibkupplung
DE112010003255A5 (de) Fördergutverteiler
BRPI1010159A2 (pt) bistuti
HK1201759A1 (en) 4-methylpyrazole formulations 4-
DE602010000025D1 (de) Fahrzeugsitzgurtvorrichtung
BRPI1013462A2 (pt) Formulações herbicidas
BR112012003616A2 (pt) metilpirroloprimidinacarboxamidas
DE112010002351A5 (de) Klemmorrichtung